2019
DOI: 10.1016/j.alit.2019.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies (AAbs) to induce FcεRI crosslinking, as compared to anti-FcεRIα AAbs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 46 publications
0
7
0
Order By: Relevance
“…In view of these shortcomings with acid-based stripping of IgE, we believe that this method could not be used for deciphering the functions of anti-IgE autoantibodies that are found in the healthy individuals and in several pathologies including atopic and non-atopic asthma, chronic spontaneous urticaria, atopic dermatitis and others [13][14][15]18,[44][45][46][47][48][49][50]. Previous reports have used myeloma IgE-coupled cyanogen bromide (CNBr)-activated Sepharose 4B columns to deplete anti-IgE autoantibodies from the serum of the patients or from the therapeutic normal IgG [14,18,19].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In view of these shortcomings with acid-based stripping of IgE, we believe that this method could not be used for deciphering the functions of anti-IgE autoantibodies that are found in the healthy individuals and in several pathologies including atopic and non-atopic asthma, chronic spontaneous urticaria, atopic dermatitis and others [13][14][15]18,[44][45][46][47][48][49][50]. Previous reports have used myeloma IgE-coupled cyanogen bromide (CNBr)-activated Sepharose 4B columns to deplete anti-IgE autoantibodies from the serum of the patients or from the therapeutic normal IgG [14,18,19].…”
Section: Discussionmentioning
confidence: 99%
“…Previous reports have used myeloma IgE-coupled cyanogen bromide (CNBr)-activated Sepharose 4B columns to deplete anti-IgE autoantibodies from the serum of the patients or from the therapeutic normal IgG [14,18,19]. In addition, micro-well coating of human myeloma IgE protein followed by incubation with purified IgG to remove anti-IgE reactivity has also been attempted [47]. As stripping of IgE on the surface of basophils would lead to an equivalent of 'IgE knock-out' basophil model, we anticipated such IgE-deficient basophils would provide convincing evidence that anti-IgE IgG autoantibodies induce human basophil activation.…”
Section: Discussionmentioning
confidence: 99%
“…IgE and IgG antibodies against thyroid peroxidase (TPO) were also found in a subgroup of CSU patients and were shown to activate mast cells ( 17 20 ). Subsequent studies have shown that IgG autoantibodies binding to FcϵRI/IgE result in mast cell degranulation and basophil activation to release a series of inflammatory mediators, finally leading to vasodilation in the lesional skin of CSU ( 14 , 21 ) ( Figure 2 ).…”
Section: Introductionmentioning
confidence: 99%
“…These laborious procedures are unsuitable for screening purposes and have limited utility for determining autoAbs titers. Many groups of researchers ever developed in-house ELISA, and these results revealed the presence of IgG anti-FcεR1α autoAbs [15][16][17]. However, how to earn and apply cut-off points was never clearly demonstrated.…”
Section: Introductionmentioning
confidence: 99%